[The use of labetalol in the so-called "post-shock phase" in intensive care patients].
D000328:Adult; D003404:Creatinine / Q000097:blood; D003422:Critical Care; D004837:Epinephrine / Q000097:blood; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D007741:Labetalol / Q000627:therapeutic use*; D008297:Male; D009638:Norepinephrine / Q000097:blood; D011674:Pulse / Q000187:drug effects; D012769:Shock / Q000150:complications*; D014554:Urination / Q000187:drug effects
D004983:Ethanolamines; D003404:Creatinine; D007741:Labetalol; D009638:Norepinephrine; D004837:Epinephrine
Die Anwendung von Labetalol in der sogenannten "Postschockphase" beim Intensivpatienten.